Product | $/unit | Ctry. | List | Type |
|
||
---|---|---|---|---|---|---|---|
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $122.6800 |
|
VA NC |
|
|||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $235.6447 |
|
AUS PBS | generic |
|
||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $425.2700 |
|
VA Big4 |
|
|||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $425.9800 |
|
VA Big4 |
|
|||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $533.8700 |
|
VA FSS |
|
|||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $547.6640 |
|
VA Big4 |
|
|||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $562.4200 |
|
VA Big4 |
|
|||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $765.7800 |
|
VA FSS |
|
|||
bevacizumab 100 mg / 4 mL (4 mL INJECTION) | $796.9400 |
|
VA FSS |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $490.7200 |
|
VA NC |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $942.5710 |
|
AUS PBS | generic |
|
||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $1696.3100 |
|
VA Big4 |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $1704.0200 |
|
VA Big4 |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $2135.5000 |
|
VA FSS |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $2176.0260 |
|
VA Big4 |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $2200.5400 |
|
VA Big4 |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $3063.1200 |
|
VA FSS |
|
|||
bevacizumab 400 mg / 16 mL (16 mL INJECTION) | $3187.7600 |
|
VA FSS |
|
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue